Integrated Research Ltd
ASX:IRI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Integrated Research Ltd
ASX:IRI
|
AU |
Integrated Research Ltd
Integrated Research Ltd. engages in the design, development, implementation, and sale of systems and applications management software. The company is headquartered in North Sydney, New South Wales and currently employs 240 full-time employees. The company went IPO on 2000-12-13. The firm's principal activities are the design, development, implementation and sale of systems and applications management computer software for business computing, unified communication (UC) networks and payment networks. Its geographical segments include the Americas, which work from the United States with responsibility for the countries in North, Central and South America; Europe, which operates from the United Kingdom and Germany with responsibility for the countries in Europe, and Asia Pacific, which operates from Australia and Singapore with responsibility for the countries in the rest of the world. The Company’s product line includes collaboration, infrastructure and transact. Its subsidiaries include Integrated Research Inc, Integrated Research Singapore Pte Limited and Integrated Research UK Limited.
Integrated Research Ltd. engages in the design, development, implementation, and sale of systems and applications management software. The company is headquartered in North Sydney, New South Wales and currently employs 240 full-time employees. The company went IPO on 2000-12-13. The firm's principal activities are the design, development, implementation and sale of systems and applications management computer software for business computing, unified communication (UC) networks and payment networks. Its geographical segments include the Americas, which work from the United States with responsibility for the countries in North, Central and South America; Europe, which operates from the United Kingdom and Germany with responsibility for the countries in Europe, and Asia Pacific, which operates from Australia and Singapore with responsibility for the countries in the rest of the world. The Company’s product line includes collaboration, infrastructure and transact. Its subsidiaries include Integrated Research Inc, Integrated Research Singapore Pte Limited and Integrated Research UK Limited.
Revenue: Statutory revenue was $28.3 million, down 2% from the prior comparable period, mainly due to a softer renewals book.
Profitability: The company reported an EBITDA loss of $3.1 million and a net after-tax loss of $1.5 million, significantly lower than the previous period's $4.6 million profit, primarily due to a material expected credit loss.
Credit Loss: A $4.8 million expected credit loss, tied to a single anomalous client, was a notable negative, but management has implemented new controls to prevent recurrence.
Cash Position: Cash increased to $43.6 million, up $3 million or 8% for the half, with no debt and strong net assets.
Product-Led Growth: The company launched new products including AI-powered Iris and Prognosis Elevate, and saw early but modest improvements in new client and expansion revenues.
Outlook & Investment: Expenses are expected to rise in the second half due to further investment in product development, and management remains focused on executing the product-led growth strategy.
